Eletriptan hydrobromide Articles

Eletriptan's efficacy rises when taken early

13 September 2004

Multinational drugmakers raising awareness of illnesses in Japan

11 August 2003

Almirall licenses triptan to Ortho-McNeil

28 April 2003

Pfizer boosted by disposals in 1st-qtr, double-digit sales and EPS growth

28 April 2003

Relpax cleared in USA after four-year review

6 January 2003

Declining drug launches in Europe drives imperative for sustained lifecycle pricing

22 July 2002

Stock Commentary - New York

4 February 2002

Pfizer gets EU approval for Relpax

15 June 2001

Pfizer forecasts strong revenue growth in 2001-2002 at R&D meeting

14 December 2000

World migraine therapy sales to 2009

14 November 2000

Pfizer and Warner-Lambert merger creates industry's largest R&D budget

10 February 2000

Pfizer reveals new products in bid to boost profile after hostile bid for

18 November 1999

Stock Commentary New York

28 October 1999

FDA requests drug interaction data for Pfizer's Relpax

26 October 1999

Pfizer counters recent setbacks with whole series of product and technology

24 June 1999

Pfizer named company of the year by Forbes

31 December 1998

Pfizer Aims For Top Slot After Millenium

10 November 1998

Showing 1-17 of 17 articles

Go to beginningPrevious
  • 1
NextGo to end